Trial reportNutrition journal2026
Accelerated recovery and alleviated pain by oral whey protein in herpes zoster patients: a randomized controlled trial.
Trial report in Nutrition journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundHerpes zoster is usually caused by varicella-zoster virus reactivation, particularly in the aged. It imposes postherpetic neuralgia and impacts life quality, which may be improved by nutritional interventions.
objectiveThis study aimed to evaluate the efficacy and mechanism of oral whey protein supplementation in the recovery, pain, and life quality of herpes zoster patients.
methodsForty herpes zoster patients were recruited in Shanghai Dermatology Hospital and randomly divided into the treatment group (n = 20) and the control group (n = 20), with normal therapy. Whey protein was orally administrated 20 g per time, twice per day. The recovery time, pain scores (VAS), dermatology life quality index (DLQI), nutritional status (PG-SGA), oxidative stress markers, and immune parameters were investigated.
resultsWhey protein supplementation significantly reduced the recovery time and scabbing time compared to controls. Pain scores were decreased, and DLQI was improved. Nutritional status (PG-SGA scores) was improved, with increased serum prealbumin. Total protein and albumin were not changed. Oral whey protein increased the GSH content and GSH-PX activity, but the SOD activity, MDA content, and NO content were not altered. The serum contents of IL-6, IFN-γ, IgG, and IgA were increased, while TNF-α, C3, C4, CRP, IgE, and IgM, were not statistically changed.
conclusionsOral whey protein adjuvant to standard therapy accelerated recovery, reduced pain, and improved quality of life in herpes zoster patients, probably by improving the nutritional status, enhancing the antioxidant system, and supporting the immune system, which highlighted the application of whey protein in herpes zoster therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.